158 related articles for article (PubMed ID: 26854986)
1. BDNF Val66Met and clinical response to antipsychotic drugs: A systematic review and meta-analysis.
Cargnin S; Massarotti A; Terrazzino S
Eur Psychiatry; 2016 Mar; 33():45-53. PubMed ID: 26854986
[TBL] [Abstract][Full Text] [Related]
2. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
[TBL] [Abstract][Full Text] [Related]
3. Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: Meta-analysis and systematic review.
González-Castro TB; Salas-Magaña M; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Hernández-Díaz Y
J Psychiatr Res; 2017 Nov; 94():208-217. PubMed ID: 28756290
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
[TBL] [Abstract][Full Text] [Related]
5. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
[TBL] [Abstract][Full Text] [Related]
6. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
[TBL] [Abstract][Full Text] [Related]
7. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
Kheirollahi M; Kazemi E; Ashouri S
Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
[TBL] [Abstract][Full Text] [Related]
8. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
[TBL] [Abstract][Full Text] [Related]
9. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
[TBL] [Abstract][Full Text] [Related]
10. The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.
Fonseka TM; Tiwari AK; Gonçalves VF; Lieberman JA; Meltzer HY; Goldstein BI; Kennedy JL; Kennedy SH; Müller DJ
World J Biol Psychiatry; 2015 Jan; 16(1):45-56. PubMed ID: 25560300
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.
Zou YF; Ye DQ; Feng XL; Su H; Pan FM; Liao FF
Eur Neuropsychopharmacol; 2010 Aug; 20(8):535-44. PubMed ID: 20167454
[TBL] [Abstract][Full Text] [Related]
12. Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.
Ieraci A; Madaio AI; Mallei A; Lee FS; Popoli M
Neuropsychopharmacology; 2016 Dec; 41(13):3070-3079. PubMed ID: 27388329
[TBL] [Abstract][Full Text] [Related]
13. BDNF Val66Met polymorphism and cognitive impairment in Parkinson's disease-a meta-analysis.
Yin Y; Su X; Pan L; Li C
Neurol Sci; 2019 Sep; 40(9):1901-1907. PubMed ID: 31104169
[TBL] [Abstract][Full Text] [Related]
14. A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.
Ahmed AO; Kramer S; Hofman N; Flynn J; Hansen M; Martin V; Pillai A; Buckley PF
Neuropsychobiology; 2021; 80(5):411-424. PubMed ID: 33706323
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits.
Frustaci A; Pozzi G; Gianfagna F; Manzoli L; Boccia S
Neuropsychobiology; 2008; 58(3-4):163-70. PubMed ID: 19088493
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume--a genuine effect or a winners curse?
Molendijk ML; Bus BA; Spinhoven P; Kaimatzoglou A; Oude Voshaar RC; Penninx BW; van IJzendoorn MH; Elzinga BM
Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):731-40. PubMed ID: 22815222
[TBL] [Abstract][Full Text] [Related]
18. Meta-analytic method reveal a significant association of theBDNF Val66Met variant with smoking persistence based on a large samples.
Zhao H; Xiong S; Li Z; Wu X; Li L
Pharmacogenomics J; 2020 Jun; 20(3):398-407. PubMed ID: 31787753
[TBL] [Abstract][Full Text] [Related]
19. Association Between the Brain-derived Neurotrophic Factor Val66Met Polymorphism and Overweight/Obesity in Pediatric Population.
Martínez-Ezquerro JD; Rendón-Macías ME; Zamora-Mendoza G; Serrano-Meneses J; Rosales-Rodríguez B; Escalante-Bautista D; Rodríguez-Cruz M; Sánchez-González R; Arellano-Pineda Y; López-Alarcón M; Zampedri MC; Rosas-Vargas H
Arch Med Res; 2017 Oct; 48(7):599-608. PubMed ID: 29506764
[TBL] [Abstract][Full Text] [Related]
20. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
